MJP Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,939
Closed -$203K 259
2025
Q2
$203K Buy
+2,939
New +$193K 0.03% 227
2023
Q3
Sell
-3,592
Closed -$248K 173
2023
Q2
$248K Sell
3,592
-872
-20% -$62K 0.08% 122
2023
Q1
$332K Buy
4,464
+53
+1% +$4.44K 0.1% 89
2022
Q4
$411K Buy
4,411
+91
+2% +$8.78K 0.12% 84
2022
Q3
$412K Buy
4,320
+538
+14% +$53.3K 0.12% 74
2022
Q2
$350K Buy
3,782
+71
+2% +$6.93K 0.1% 86
2022
Q1
$376K Buy
+3,711
New +$390K 0.09% 94
2021
Q1
Sell
-3,264
Closed -$223K 131
2020
Q4
$223K Buy
+3,264
New +$212K 0.09% 106

Other funds holding CVS

MJP Associates's CVS Position: Q3 2025 in Review

MJP Associates sold out of CVS Health (CVS) in Q3 2025, closing a stake of 2,939 shares — an estimated $203K sold.

MJP Associates first reported a position in CVS in Q4 2020 and held it in 8 quarters. The position peaked at $412K in Q3 2022. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • MJP Associates reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • MJP Associates sold 2,939 CVS Health shares in Q3 2025, an estimated $203K.
  • MJP Associates first reported a position in CVS Health in Q4 2020 and held it in 8 quarters.
  • MJP Associates's CVS Health position peaked at $412K in Q3 2022.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on MJP Associates's 13F filing for Q3 2025, filed 7 Nov 2025.